Centrifugation Conditions in the L-PRP Preparation Affect Soluble Factors Release and Mesenchymal Stem Cell Proliferation in Fibrin Nanofibers

• Main Authors: Bruna Alice Gomes de Melo, Ângela Cristina Malheiros Luzo, José Fabio Santos Duarte Lana, Maria Helena Andrade Santana
• Format: Article
• Language: English
• Published: MDPI AG 2019-07-01
• Series: Molecules
• Subjects: platelet; leukocyte; L-PRP; centrifugation; fibrin; nanofiber; growth factor; cytokine; mesenchymal stem cells
• Online Access: https://www.mdpi.com/1420-3049/24/15/2729

Leukocyte and platelet-rich plasma (L-PRP) is an autologous product that when activated forms fibrin nanofibers, which are useful in regenerative medicine. As an important part of the preparation of L-PRP, the centrifugation parameters may affect the release of soluble factors that modulate the behavior of the cells in the nanofibers. In this study, we evaluated the influences of four different centrifugation conditions on the concentration of platelets and leukocytes in L-PRP and on the anabolic/catabolic balance of the nanofiber microenvironment. Human adipose-derived mesenchymal stem cells (h-AdMSCs) were seeded in the nanofibers, and their viability and growth were evaluated. L-PRPs prepared at 100&#215; <i>g</i> and 100 + 400&#215; <i>g</i> released higher levels of transforming growth factor (TGF)-&#946;1 and platelet-derived growth factor (PDGF)-BB due to the increased platelet concentration, while inflammatory cytokines interleukin (IL)-8 and tumor necrosis factor (TNF)-&#945; were more significantly released from L-PRPs prepared via two centrifugation steps (100 + 400&#215; <i>g</i> and 800 + 400&#215; <i>g</i>) due to the increased concentration of leukocytes. Our results showed that with the exception of nanofibers formed from L-PRP prepared at 800 + 400&#215; <i>g</i>, all other microenvironments were favorable for h-AdMSC proliferation. Here, we present a reproducible protocol for the standardization of L-PRP and fibrin nanofibers useful in clinical practices with known platelet/leukocyte ratios and in vitro evaluations that may predict in vivo results.